Obesity-resistant S5B rats showed greater cocaine conditioned place preference than the obesity-prone OM rats

Physiology and Behavior

Volumn 101, Issue 5, 2010, Pages 713-718

  Thanos, Panayotis K ^a,b,c   Kim, Ronald ^b,c   Cho, Jacob ^b   Michaelides, Michael ^b,c   Anderson, Brenda J ^c   Primeaux, Stefany D ^d   Bray, George A ^d   Wang, Gene Jack ^b   Robinson, John K ^c   Volkow, Nora D ^a  

^a NATIONAL INSTITUTE ON ALCOHOL ABUSE AND ALCOHOLISM   (United States)

^b BROOKHAVEN NATIONAL LABORATORY   (United States)

^c STONY BROOK UNIVERSITY   (United States)

^d PENNINGTON BIOMEDICAL RESEARCH CENTER   (United States)

Author keywords

Addiction; Bromocriptine; Conditioned place preference; Psychostimulant

Indexed keywords

BROMOCRIPTINE; COCAINE; SODIUM CHLORIDE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; MALE; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT;

ANALYSIS OF VARIANCE; ANIMALS; ASSOCIATION LEARNING; BROMOCRIPTINE; COCAINE; CONDITIONING (PSYCHOLOGY); DOPAMINE AGONISTS; DOPAMINE UPTAKE INHIBITORS; MALE; OBESITY; RATS; RECEPTORS, DOPAMINE D2;

EID: 78149286114     PISSN: 00319384     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.physbeh.2010.08.011     Document Type: Article

References (41)

1. Flegal K.M., Williamson D.F., Pamuk E.R., Rosenberg H.M. Estimating deaths attributable to obesity in the United States. Am J Public Health 2004, 94(9):1486-1489.
2. Volkow N.D., Li T.-K. Drugs and alcohol: Treating and preventing abuse, addiction and their medical consequences. Pharmacol Ther 2005, 108(1):3-17.
3. Volkow N.D., Wang G.J., Fowler J.S., Telang F. Overlapping neuronal circuits in addiction and obesity: evidence of systems pathology. Philos Trans R Soc Lond B Biol Sci 2008, 363(1507):3191-3200.
4. Volkow N.D., Wise R.A. How can drug addiction help us understand obesity?. Nat Neurosci 2005, 8(5):555-560.
5. Wang G.J., Volkow N.D., Thanos P.K., F.J.S Positron emission tomographic evidence of similarity between obesity and drug addiction. Psychiatr Ann 2003, 33(2):104-111.
6. Wang G., Volkow N., Thanos P., Fowler J. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review. J Addict Dis 2004, 23(3):39-53.
7. Wang G.J., Volkow N.D., Thanos P.K., Fowler J.S. Similarity between obesity and drug addiction as assessed by neurofunctional imaging: a concept review. J Addict Dis 2004, 23(3):39-53.
8. Volkow N., Wang G., Fishman N., Foltin R., Fowler J., Abumrad N., et al. Relationship between subjective effects of cocaine and dopamine transporter occupancy. Nature 1997, 6627:827-830.
9. Chen P.S., Yang Y.K., Yeh T.L., Lee I.H., Yao W.J., Chiu N.T., et al. Correlation between body mass index and striatal dopamine transporter availability in healthy volunteers-A SPECT study. Neuroimage 2008, 40(1):275-279.
10. Huang X.-F., Zavitsanou K., Huang X., Yu Y., Wang H., Chen F., et al. Dopamine transporter and D2 receptor binding densities in mice prone or resistant to chronic high fat diet-induced obesity. Behav Brain Res 2006, 175(2):415-419.
11. Wang G., Volkow N., Logan J., Pappas N., Wong C., Zhu W., et al. Brain dopamine and obesity. Lancet 2001, 357(9253):354-357.
12. Hamdi A., Porter J., Prasad C. Decreased striatal D2 dopamine receptors in obese Zucker rats: changes during aging. Brain Res 1992, 589(2):338-340.
13. Thanos P., Michaelides M., Piyis Y., Wang G., Volkow N. Food restriction markedly increases dopamine D2 receptor (D2R) in a rat model of obesity as assessed with in-vivo muPET imaging ([(11)C] raclopride) and in-vitro ([(3)H] spiperone) autoradiography. Synapse 2008, 62(1):50-61.
14. Stice E., Spoor S., Bohon C., Small D.M. Relation between obesity and blunted striatal response to food is moderated by TaqIA A1 allele. Science 2008, 322(5900):449-452.
15. Volkow N.D., Fowler J.S., Wang G.J., Hitzemann R., Logan J., Schlyer D.J., et al. Decreased dopamine D2 receptor availability is associated with reduced frontal metabolism in cocaine abusers. Synapse 1993, 14(2):169-177.
16. McBride W.J., Chernet E., Russell R.N., Chamberlain J.K., Lumeng L., Li T.K. Regional CNS densities of serotonin and dopamine receptors in high alcohol-drinking (HAD) and low alcohol-drinking (LAD) rats. Alcohol 1997, 14(6):603-609.
17. Thanos, PK, Michaelides M, Umegaki H, and Volkow ND. D2R DNA Transfer Into the Nucleus Accumbens Attentuates Cocaine Self Administration in Rats Synapse, 2008. 62(5): p. 481-6.
18. Thanos P.K., Taintor N.B., Rivera S.N., Umegaki H., Ikari H., Roth G., et al. DRD2 gene transfer into the nucleus accumbens core of the alcohol preferring and nonpreferring rats attenuates alcohol drinking. Alcohol Clin Exp Res 2004, 28(5):720-728.
19. Davis J.F., Tracy A.L., Schurdak J.D., Tschöp M.H., Lipton J.W., Clegg D.J., et al. Exposure to elevated levels of dietary fat attenuates psychostimulant reward and mesolimbic dopamine turnover in the rat. Behav Neurosci 2008, 122(6):1257-1263.
20. Schaffhauser A.O., Madiehe A.M., Braymer H.D., Bray G.A., York D.A. Effects of a high-fat diet and strain on hypothalamic gene expression in rats. Obes Res 2002, 10(11):1188-1196.
21. Smith, KR. Understanding Obesity through a Comparison of Osborne-Mendel and S5B/P1 Strains of Rat. A critical literature review submitted in partial fulfillment of the requirements for the senior research thesis, 2006.
22. Nagase H., Bray G.A., York D.A. Pyruvate and hepatic pyruvate dehydrogenase levels in rat strains sensitive and resistant to dietary obesity. Am J Physiol Regul Integr Comp Physiol 1996, 270:489-495.
23. Schemmel R., Mickelsen O., Gill J.L. Dietary Obesity in Rats: Body Weight and Body Fat Accretion in Seven Strains of Rats. J Nutr 1969, 100:1041-1048.
24. Davis L.M., Michaelides M., Cheskin L.J., Moran T.H., Aja S., Watkins P.A., et al. Bromocriptine administration reduces hyperphagia and adiposity and differentially affects dopamine D2 receptor and transporter binding in leptin-receptor-deficient Zucker rats and rats with diet-induced obesity. Neuroendocrinology 2009, 89(2):152-162.
25. NAS and NRC Guide for the Care and Use of Laboratory Animals 1996, National Academy Press, Washington D.C.
26. Cincotta A.H., Meier A.H. Reductions of body fat stores and total plasma cholesterol and triglyceride concentrations in several species by bromocriptine treatment. Life Sci 1989, 45(23):2247-2254.
27. Christensen C.J., Kohut S.J., Handler S., Silberberg A., Riley A.L. Demand for food and cocaine in Fischer and Lewis rats. Behav Neurosci 2009, 123:165-171.
28. Carr K.D. Chronic food restriction: enhancing effects on drug reward and striatal cell signaling. Physiol Behav 2007, 91(5):459-472.
29. Wellman P.J., Nation J.R., Davis K.W. Impairment of acquisition of cocaine self-administration in rats maintained on a high-fat diet. Pharmacol Biochem Behav 2007, 88(1):89-93.
30. Lenoir M., Serre F., Cantin L., Ahmed S.H. Intense Sweetness Surpasses Cocaine Reward. PLoS ONE 2007, 2(8):e698.
31. Hubner C., Koob G.F. Bromocriptine produces decreases in cocaine self-administration in the rat. Neuropsychopharmacology 1990, 3(2):101-108.
32. Koob G., Weiss F., Deroche V., Weissenborn R. Effects of dopamine agonists and antagonists on cocaine-induced operant responding for a cocaine-associated stimulus. Psychopharmacology (Berl) 1996, 126(4):311-322.
33. Davis L.M., Pei Z., Trush M.A., Cheskin L.J., Contoreggi C., McCullough K., et al. Bromocriptine reduces steatosis in obese rodent models. J Hepatol 2006, 45(3):439-444.
34. Corrigall W.A., Coen K.M. Cocaine self-administration is increased by both D1 and D2 dopamine antagonists. Pharmacol Biochem Behav 1991, 39(3):799-802.
35. Hubner C.B., Moreton E.J. Effects of Selective D1 and D2 Dopamine Antagonists on Cocaine Self-Administration in the Rat. Psychopharmacology 1991, 105:151-156.
36. Koob G.F., Le H.T., Creese I. The D1 Dopamine Receptor Antagonist SCH 23390 Increases Cocaine Self-Administration in the Rat. Neurosci Lett 1987, 79:315-320.
37. Vorel S.R., Ashby C.R., Paul M., Liu X., Hayes R., Hagan J.J., et al. Dopamine D3 receptor antagonism inhibits cocaine-seeking and cocaine-enhanced brain reward in rats. J Neurosci 2002, 22(21):9595-9603.
38. Sora I., Wichems C., Takahashi N., Li X.F., Zeng Z., Revay R., et al. Cocaine reward models: conditioned place preference can be established in dopamine- and in serotonin-transporter knockout mice. Proc Natl Acad Sci USA 1998, 95(13):7699-7704.
39. Baker D.A., Fuchs R.A., Specio S.E., Khroyan T.V., Neisewander J.L. Effects of intraaccumbens administration of SCH-23390 on cocaine- induced locomotion and conditioned place preference. Synapse 1998, 30(2):181-193.
40. Handelsman L., Rosenblum A., Palij M., Magura S., Foote J., Lovejoy M., et al. Bromocriptine for cocaine dependence. A controlled clinical trial. Am J Addict 1997, 6(1):54-64.
41. Gorelick D.A., Wilkins J.N. Bromocriptine treatment for cocaine addiction: Association with plasma prolactin levels. Drug Alcohol Depend 2006, 81:189-195.